The New WHO Classification for Essential Thrombocythemia Calls for Revision of Available Evidences

Blood Cancer Journal - United States
doi 10.1038/s41408-020-0290-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Field-Testing the New Anaphylaxis' Classification for the WHO International Classification of Diseases-11 Revision

Allergy: European Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Practice-Relevant Revision of Ipset-Thrombosis Based on 1019 Patients With WHO-Defined Essential Thrombocythemia

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Essential Thrombocythemia

New England Journal of Medicine
Medicine
2020English

Essential Thrombocythemia

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2007English

Incidence and Risk Factors for Bleeding in 1104 Patients With Essential Thrombocythemia or Prefibrotic Myelofibrosis Diagnosed According to the 2008 WHO Criteria

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

WHO Calls for Safety of Health Workers in Palestinian Territories

BMJ
2002English

WHO Essential Medicines for Reproductive Health

BMJ Global Health
Health PolicyPublic HealthOccupational HealthEnvironmental
2019English

Advances and Challenges in the Management of Essential Thrombocythemia

Therapeutic Advances in Hematology
Hematology
2015English

Updates in the Management of Polycythemia Vera and Essential Thrombocythemia

Therapeutic Advances in Hematology
Hematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy